FDA Releases Guidance for Conducting Clinical Trials During Disasters and Public Health Emergencies

Summary

The US Food and Drug Administration (FDA) has published a final guidance document outlining recommendations for conducting clinical trials of medical products during major disruptions caused by disasters and public health emergencies, such as hurricanes, earthquakes, and infectious disease outbreaks.